Cargando…

Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment

Detalles Bibliográficos
Autores principales:	Covre, Alessia, Parisi, Giulia, Nicolay, Hugues JMG, Fazio, Carolina, Fonsatti, Ester, Fratta, Elisabetta, Sigalotti, Luca, Taverna, Pietro, Choy, Gavin, Azab, Mohammad, Coral, Sandra, Maio, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990977/ http://dx.doi.org/10.1186/2051-1426-1-S1-P71

Ejemplares similares

Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications
por: Coral, S, et al.
Publicado: (2012)

Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts
por: Srivastava, Pragya, et al.
Publicado: (2015)

Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
por: Sigalotti, Luca, et al.
Publicado: (2010)

Simultaneous Modeling of Biomarker and Toxicity Response Predicted Optimal Regimen of Guadecitabine (SGI‐110) in Myeloid Malignancies
por: Xu, Cong, et al.
Publicado: (2017)

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
por: Jueliger, Simone, et al.
Publicado: (2016)

Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?
por: Sigalotti, L, et al.
Publicado: (2011)

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients
por: Sigalotti, Luca, et al.
Publicado: (2011)

Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
por: Sigalotti, Luca, et al.
Publicado: (2012)

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
por: Wong, Jonathan, et al.
Publicado: (2022)

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy
por: Fazio, Carolina, et al.
Publicado: (2018)

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors
por: Papadatos-Pastos, Dionysis, et al.
Publicado: (2022)

DNA methylation subtypes guiding prognostic assessment and linking to responses the DNA methyltransferase inhibitor SGI-110 in urothelial carcinoma
por: Li, Juan, et al.
Publicado: (2022)

Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
por: Fonsatti, Ester, et al.
Publicado: (2004)

The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma
por: Montico, Barbara, et al.
Publicado: (2021)

Two New SGI1-LK Variants Found in Proteus mirabilis and Evolution of the SGI1-HKL Group of Salmonella Genomic Islands
por: de Curraize, Claire, et al.
Publicado: (2020)

3rd European Cray/SGI MPP Workshop
Publicado: (1997)

5th European SGI-Cray MPP Workshop
Publicado: (1999)

SGI: automatic clinical subgroup identification in omics datasets
por: Buyukozkan, Mustafa, et al.
Publicado: (2021)

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study
por: Maccalli, Cristina, et al.
Publicado: (2013)

Erratum for de Curraize et al., “Two New SGI1-LK Variants Found in Proteus mirabilis and Evolution of the SGI1-HKL Group of Salmonella Genomic Islands”
por: de Curraize, Claire, et al.
Publicado: (2020)

Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?
por: Fonsatti, Ester, et al.
Publicado: (2004)

Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics()
por: Bonavida, Benjamin, et al.
Publicado: (2015)

The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward
por: Maio, Michele, et al.
Publicado: (2008)

Immunomodulatory activity of manganese dioxide nanoparticles: Promising for novel vaccines and immunotherapeutics
por: Huang, Yuhe, et al.
Publicado: (2023)

SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial
por: Crabb, Simon, et al.
Publicado: (2018)

Loss of Spry1 reduces growth of BRAF(V600)-mutant cutaneous melanoma and improves response to targeted therapy
por: Montico, Barbara, et al.
Publicado: (2020)

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023)

Immunomodulatory and immunotherapeutic implications of tobacco smoking in squamous cell carcinomas and normal airway epithelium
por: Wang, Jingming, et al.
Publicado: (2019)

“Does the Salmonella Genomic Island 1 (SGI1) confer invasiveness properties to human isolates?”
por: de Curraize, Claire, et al.
Publicado: (2017)

DNMTs inhibitor SGI-1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells
por: Sun, Ning, et al.
Publicado: (2018)

Identification and Characterization of New Resistance-Conferring SGI1s (Salmonella Genomic Island 1) in Proteus mirabilis
por: Bie, Luyao, et al.
Publicado: (2018)

SGI-4 in Monophasic Salmonella Typhimurium ST34 Is a Novel ICE That Enhances Resistance to Copper
por: Branchu, Priscilla, et al.
Publicado: (2019)

Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells.
por: Fonsatti, E., et al.
Publicado: (1997)

Detection of SGI1/PGI1 Elements and Resistance to Extended-Spectrum Cephalosporins in Proteae of Animal Origin in France
por: Schultz, Eliette, et al.
Publicado: (2017)

Preclinical characterization of the JAK/STAT inhibitor SGI-1252 on skeletal muscle function, morphology, and satellite cell content
por: Sorensen, Jacob R., et al.
Publicado: (2018)

Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens
por: Cerbone, Luigi, et al.
Publicado: (2023)

Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies
por: Fratta, Elisabetta, et al.
Publicado: (2016)

Molecular Modeling Studies of the Novel Inhibitors of DNA Methyltransferases SGI-1027 and CBC12: Implications for the Mechanism of Inhibition of DNMTs
por: Yoo, Jakyung, et al.
Publicado: (2013)

Salmonella genomic island 1 (SGI1) reshapes the mating apparatus of IncC conjugative plasmids to promote self-propagation
por: Carraro, Nicolas, et al.
Publicado: (2017)

The master regulator of IncA/C plasmids is recognized by the Salmonella Genomic island SGI1 as a signal for excision and conjugal transfer
por: Kiss, János, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qp4nkhvnoqsc8n7sa65aqqcibj